EUVIMEDEUVIMED entdecken
Crossref

Transjugular Approach for Evoque Transcatheter Tricuspid Valve Replacement in Patients With Challenging Anatomy

Jonathan X Fang iD, Pedro A Villablanca iD, Tiberio M Frisoli iD, Gennaro Giustino, Leo Kar Lok Lai, James C Lee iD, Pedro Engel Gonzalez, Bryan Zweig iD, Hussayn Alrayes, Georgi K Fram, Felix Nguyen iD, Ahmad Jabri iD und 5 weitere

Circulation: Cardiovascular Interventions · 2025

DOI: 10.1161/circinterventions.125.015276 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Circulation: Cardiovascular Interventions, 2025. Verfasst von Jonathan X Fang und 16 weiteren Autor:innen. Beteiligte Einrichtung: Center for Structural Heart Disease, Henry Ford Health System, Detroit, MI (J.X.F., P.A.V., T.M.F., L.K.L.L., J.C.L., P.E.G., B.Z., H.A., G.K.F., F.N…. Hauptthemen laut MEDLINE: Tricuspid Valve, Heart Valve Prosthesis Implantation, Cardiac Catheterization, Tricuspid Valve Insufficiency. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 8 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND: The Evoque system is the first commercially available transcatheter tricuspid valve replacement (TTVR) system in the United States. However, challenging anatomy in real-world patients could preclude successful transfemoral Evoque TTVR. We aim to investigate the feasibility of the transjugular Evoque TTVR in anatomy unsuitable for a transfemoral approach. METHODS: Eleven patients with challenging anatomy underwent transjugular Evoque TTVR at a high-volume center in the United States from February 2024 to January 2025, following an unsuccessful transfemoral attempt (n=9) or anatomic unsuitability (n=2). Procedural characteristics, intraprocedural success, periprocedural outcomes, echocardiographic findings, and 30-day clinical outcomes were assessed using the Tricuspid Valve Academic Research Consortium definitions. The procedural technique is provided in the accompanying supplement. RESULTS: Intraprocedural success was achieved in all 11 patients, with reasonable procedural time and no major procedural complications, except for 1 pacemaker implantation. At 30 days, the clinical success rate was 100%. Tricuspid regurgitation was reduced to none-to-trivial in 8 patients, mild in 2 patients, and moderate in 1 patient. There was no stroke, mortality, or rehospitalization. Nine out of 11 patients experienced an improvement in New York Heart Association functional class. CONCLUSIONS: In the largest single-center cohort of patients reported to date, transjugular Evoque TTVR demonstrated favorable intraprocedural, periprocedural, and short-term clinical outcomes, and was found to be a feasible alternative for patients with anatomy unsuitable for transfemoral Evoque TTVR.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Tricuspid ValveHeart Valve Prosthesis ImplantationCardiac CatheterizationTricuspid Valve InsufficiencyHeart Valve ProsthesisJugular VeinsHumansMaleFemaleTreatment OutcomeFeasibility StudiesAgedAged, 80 and overTime FactorsRetrospective StudiesMiddle AgedRecovery of FunctionProsthesis DesignRisk Factors

Stichwörter der Autor:innen

Evoquealternative accesshumanstranscatheter tricuspid valve replacementtricuspid regurgitation

Autor:innen und Institutionen

  • Center for Structural Heart Disease, Henry Ford Health System, Detroit, MI (J.X.F., P.A.V., T.M.F., L.K.L.L., J.C.L., P.E.G., B.Z., H.A., G.K.F., F.N., T.A., O.A., G.R., W.W.O.N., B.P.O.N.).
  • National Heart Centre Singapore (J.X.F.).
  • Gagnon Cardiovascular Institute, Morristown Medical Center, Atlantic Health System, NJ (G.G.).
  • Prince of Wales Hospital, Hong Kong, China (L.K.L.L.).
  • Corewell Health William Beaumont University Hospital, Royal Oaks, MI (A.J.).

ORCID-Profile: Jonathan X Fang, Pedro A Villablanca, Tiberio M Frisoli, James C Lee, Bryan Zweig, Felix Nguyen, Ahmad Jabri, Omar Abdelhai, William W O'Neill

Zitieren

APA

Fang, J. X., Villablanca, P. A., Frisoli, T. M., Giustino, G., Lai, L. K. L., Lee, J. C., Engel Gonzalez, P., Zweig, B., Alrayes, H., Fram, G. K., Nguyen, F., Jabri, A., Andrews, T., Abdelhai, O., Rangavajla, G., O'Neill, W. W., & O'Neill, B. P. (2025). Transjugular Approach for Evoque Transcatheter Tricuspid Valve Replacement in Patients With Challenging Anatomy. Circulation: Cardiovascular Interventions. https://doi.org/10.1161/circinterventions.125.015276

Vancouver

Fang JX, Villablanca PA, Frisoli TM, Giustino G, Lai LKL, Lee JC, et al. Transjugular Approach for Evoque Transcatheter Tricuspid Valve Replacement in Patients With Challenging Anatomy. Circulation: Cardiovascular Interventions. 2025. doi:10.1161/circinterventions.125.015276

BibTeX
@article{Fang2025,
  author = {Fang, Jonathan X and Villablanca, Pedro A and Frisoli, Tiberio M and Giustino, Gennaro and Lai, Leo Kar Lok and Lee, James C and Engel Gonzalez, Pedro and Zweig, Bryan and Alrayes, Hussayn and Fram, Georgi K and Nguyen, Felix and Jabri, Ahmad and Andrews, Tyler and Abdelhai, Omar and Rangavajla, Gautam and O'Neill, William W and O'Neill, Brian P},
  title = {Transjugular Approach for Evoque Transcatheter Tricuspid Valve Replacement in Patients With Challenging Anatomy},
  journal = {Circulation: Cardiovascular Interventions},
  year = {2025},
  doi = {10.1161/circinterventions.125.015276}
}
Kostenlos starten →